Cargando…
Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3
The current pneumococcal capsular polysaccharide (PPS) conjugate vaccine (PCV13) is less effective against Streptococcus pneumoniae serotype 3 (ST3), which remains a major cause of pneumococcal disease and mortality. Therefore, dissecting structure-function relationships of human ST3 pneumococcal ca...
Autores principales: | Babb, Rachelle, Doyle, Christopher R., Pirofski, Liise-anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579928/ https://www.ncbi.nlm.nih.gov/pubmed/34756090 http://dx.doi.org/10.1128/Spectrum.01446-21 |
Ejemplares similares
-
647. Characterization and Development of Human Monoclonal Antibodies to Pneumococcal Serotype 3
por: Babb, Rachelle, et al.
Publicado: (2018) -
A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies
por: Ozdilek, Ahmet, et al.
Publicado: (2021) -
Antibodies to Streptococcus pneumoniae Capsular Polysaccharide Enhance Pneumococcal Quorum Sensing
por: Yano, Masahide, et al.
Publicado: (2011) -
Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody
por: Doyle, Christopher R., et al.
Publicado: (2016) -
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage
por: Mitsi, E, et al.
Publicado: (2016)